The proPSMA study (A prospective multicentre study of the impact of Ga-68 PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy)

Project Member(s): De Abreu Lourenco, R.

Funding or Partner Organisation: Prostate Cancer Foundation of Australia (Prostate Cancer Foundation Australia)
Prostate Cancer Foundation of Australia (Prostate Cancer Foundation Australia)

Start year: 2017

Publications:

Hofman, MS, Murphy, DG, Williams, SG, Nzenza, T, Herschtal, A, Lourenco, RDA, Bailey, DL, Budd, R, Hicks, RJ, Francis, RJ & Lawrentschuk, N 2018, 'A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol', BJU International, vol. 122, no. 5, pp. 783-793.
View/Download from: Publisher's site

FOR Codes: Health Economics, Health Policy Evaluation, Health Policy Economic Outcomes, Health economics , Evaluation of health and support services not elsewhere classified

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.